Risk adjusted net present value: What is the current valuation of PMV Pharmaceuticals’s Rezatapopt?
Rezatapopt is a small molecule commercialized by PMV Pharmaceuticals, with a leading Phase II program in Endometrial Cancer.
Rezatapopt is a small molecule commercialized by PMV Pharmaceuticals, with a leading Phase II program in Endometrial Cancer.
What's Your Reaction?
